Circulating levels of cyclosporin A in inflammatory bowel disease: Relationships with lymphocyte inhibition and the age of patients

European Journal of Clinical Pharmacology

Volumn 60, Issue 3, 2004, Pages 161-164

  Angeloni, Giulia ^a   Latteri, Miriam ^b   Manna, Raffaele ^c   Rumi, Carlo ^c   Gasbarrini, Giovanni ^c   Navarra, Pierluigi ^c  

^a Ctro Ric Formazione ad Alta T   (Italy)

^b Ospedale Civile   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cyclosporin A; Inflammatory bowel disease; Lymphocyte

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; ENTERITIS; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE; MALE; MICROEMULSION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADULT; CELL AGING; CELL DIVISION; COLITIS, ULCERATIVE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; EMULSIONS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 2942627768     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0743-2     Document Type: Article

References (17)

1. Batiuk TD, Kung L, Halloran PF (1997) Evidence that calcineurin is rate-limiting for primary human lymphocyte activation. J Clin Invest 100:1894-1901
2. Halloran PF, Kung L, Noujaim J (1998) Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc 30:2167-2170
3. Latteri M, Angeloni G, Gentiloni Silveri N, Manna R, Gasbarrini G, Navarra P (2001) Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease. Clin Pharmacokinet 40:473-483
4. Mitsuyama K, Suzuki A, Tomiyasu N, Takaki K, Toyonaga A, Sata M (2001) Transcription factor-targeted therapies in inflammatory bowel disease. Digestion 63[Suppl 1]:68-72
5. Bussa S, Rumi C, Leone G, Bizzi B (1993) Evaluation of a new whole blood cytometric lymphocyte transformation test for immunological screenings. J Clin Lab Immunol 40:39-46
6. d'Uscio CH, Aweeka FT, Prueksaritanont T, Tomlanovich SJ, Gupta SK, Lantz MV, Gambertoglio JG, Garovoy MR, Benet LZ (1995) Immunopharmacodynamic studies of cyclosporine in patients awaiting renal transplantation. J Clin Pharmacol 10:967-973
7. Fukuda T, Asakawa J, Motojima S, Makino S (1995) Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma. Ann Allergy Asthma Immunol 75:65-72
8. Mora JR, Bono MR, Rosemblatt M, Rodriguez S, Morales J, Buckel E, Fierro A (2001) CD4 and CD8 cytokine-producing T cells are transiently reduced following cyclosporine intake: maximal inhibition occurs at 2 hours coincidental with drug C(max). Transplant Proc 33:3310-3312
9. Briggs WA, Gao ZH, Gimenez LF, Scheel PJ Jr, Choi MJ, Burdick JF (1996) Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both. J Clin Pharmacol 36:707-714
10. Hirano T, Oka K, Takeuchi H, Kozaki K, Matsuno N, Nagao T, Kozaki M, Ichikawa M, Yoshida M, Umezawa Y, Hirata M, Oh-i T, Koga M (1997) Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy. Clin Pharmacol Ther 62:652-664
11. Briggs WA, Eustace J, Mathew S, Gimenez LF, Choi M, Scheel PJ Jr, Burdick J (1998) Pentoxifylline potentiates in vitro lymphocyte suppression by glucocorticoids and immunosuppressive drugs. J Clin Pharmacol 38:561-566
12. Briggs WA, Eustace J, Gimenez LF, Choi MJ, Scheel PJ Jr, Burdick JF (1999) Lymphocyte suppression by glucocorticoids with cyclosporine, tacrolimus, pentoxifylline, and mycophenolic acid. J Clin Pharmacol 39:125-130
13. McCormack G, O'Donoghue D, Baird A (2001) In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis. Aliment Pharmacol Ther 15:665-668
14. Stio M, Treves C, Celli A, Tarantino O, d'Albasio G, Bonanomi AG (2002) Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis. Am J Gastroenterol 97:679-689
15. Woodside KJ, Hu M, Meng T, Hunter GC, Sower LE, Daller JA (2003) Differential effects of interleukin-2 blockade on apoptosis in naive and activated human lymphocytes. Transplantation 75:1631-1635
16. Morales JM, Campistol JM, Andres A, Herrero JC (2000) Immunosuppression in older renal transplant patients. Drugs Aging 16:279-287
17. Bradley BA (2002) Rejection and recipient age. Transpl Immunol 10:125-132